腫瘍の微小環境における免疫抑制メカニズムの観点から,進行した胃がん患者の組み合わせ免疫療法の開発
Kosaku Mimura1,2, Koji Kono1
1Department of Gastrointestinal Tract Surgery, Fukushima Medical University School of Medicine.
Fukushima journal of medical science
|September 3, 2025
まとめ
プログラムされた細胞死1 (PD-1) 抗モノクローナル抗体 (mAbs) を併用した組み合わせ免疫療法は,進行した胃がん (GC) に対して有望である. このアプローチは,腫瘍の微小環境における免疫抑制メカニズムをターゲットにすることで,抵抗を克服することを目的としています.
科学分野:
- 腫瘍学
- 免疫学
- 癌 研究
背景:
- プログラムされた細胞死1抗 (PD-1) モノクローナル抗体 (mAbs) の単独治療は,進行した胃がん (GC) の治療に限られた有効性を示しています.
- 腫瘍の微小環境 (TME) には,免疫抑制細胞と抑制性免疫チェックポイント分子が含まれて,細胞毒性Tリンパ球 (CTL) の機能を阻害する免疫抑制メカニズムが含まれています.
- 抗PD-1 mAb治療の有効性を高めるには,CTL数と機能の改善が不可欠です.
研究 の 目的:
- 先進的なGCに対する組み合わせ免疫療法の治療可能性を検討する.
- TME内の阻害性免疫チェックポイント分子と免疫抑制細胞を標的とした戦略に焦点を当てます.
- 放射線療法による免疫性腫瘍細胞死 (ICD) の役割を研究する.
主な方法:
- 進行した胃がんに対する免疫療法に関する現在の文献のレビュー.
- TMEにおける免疫抑制メカニズムの分析
- 抗PD-1 mAbs,チェックポイント阻害剤,ICD誘導を含む組み合わせ戦略の検討.
主要な成果:
- GCにおける抗PD-1 mAbの有効性を高めるための結合免疫療法戦略が開発されています.
- TME内の免疫抑制細胞とチェックポイント分子をターゲットにすることで,CTL応答を増加させることができます.
- 放射線療法によるICDは,がん免疫サイクルを活性化し,免疫療法と潜在的に連携します.
結論:
- 併用免疫療法は,進行したGCの治療に有意義な可能性を秘めている.
- TME媒介の免疫抑制を克服することは 患者のアウトカムを改善する鍵です
- ICD誘導とチェックポイント阻害を統合することは,将来のGC治療戦略にとって有望な道を提供します.
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


